List

Truth Social post of June 25, 2026

PostStatementPublished 06/25Open the original

Summary

President Trump announces the nomination of Chris Klomp as Deputy Secretary of HHS, saying he has led Medicare operations and will drive reforms including the Most Favored Nation drug pricing policy.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/06/240.0%0.0%
26/06/25+1.1%−0.4%
26/06/26+3.4%−0.9%
26/06/29+3.2%+0.5%
26/06/30+2.5%+1.2%
26/07/01+3.1%+1.1%
26/07/02+5.5%+0.9%
26/07/06+3.9%+1.9%
26/07/07+6.0%+1.4%
26/07/08+5.7%+1.0%
26/07/09+5.0%+1.9%
26/07/10+4.4%+2.5%
26/07/13+5.5%+1.5%
26/07/14+4.1%+2.0%
26/07/15+3.3%+2.4%
26/07/16+5.0%+1.7%
26/07/17+5.0%+0.7%
26/07/20+4.1%+0.6%
26/07/21+5.3%+1.4%
26/07/22+4.5%+1.2%
26/07/23+5.3%+0.2%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Dermot Mark Durcan

    BuyCencora

    $1.1M

    Filed 06/22

  • Dermot Mark Durcan

    BuyCencora

    $1.1M

    Filed 05/28

  • Lauren M. Tyler

    BuyCencora

    $148.6K

    Filed 06/24

  • John Boozman

    BuyUnitedhealth Group

    $1K–$15K

    Reported 07/13

  • Kathryn E. Wengel

    SellJohnson & Johnson

    $2.4M

    Filed 06/12

  • Daniel Patrick O'Day

    Sell10b5-1 planGilead Sciences

    $1.4M

    Filed 06/02

  • Tommy Tuberville

    Full salePfizer

    $15K–$50K

    Reported 07/16

  • Brian S. Tyler

    Sell10b5-1 planMcKesson

    $6.6M

    Filed 06/18

  • Daniel Patrick O'Day

    Sell10b5-1 planGilead Sciences

    $404.9K

    Filed 06/02

  • Andrew D. Dickinson

    Sell10b5-1 planGilead Sciences

    $376.2K

    Filed 06/16

  • Brian S. Tyler

    Sell10b5-1 planMcKesson

    $3.8M

    Filed 06/11

  • Thomas Kean

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 07/15

  • Thomas Kean

    Partial saleJohnson & Johnson

    $1K–$15K

    Reported 07/15

  • Rick Larsen

    BuyMcKesson

    $1K–$15K

    Reported 07/12

  • Ilya Yuffa

    Sell10b5-1 planELI Lilly

    $2.9M

    Filed 06/11

  • Daniel Patrick O'Day

    Sell10b5-1 planGilead Sciences

    $138K

    Filed 06/02

  • Jennifer B. Damico

    SellPfizer

    $51.4K

    Filed 06/10

  • Dan Newhouse

    Full saleUnitedhealth Group

    $1K–$15K

    Reported 07/17

  • Maria Salazar

    Full saleUnitedhealth Group

    $1K–$15K

    Reported 07/07

  • Michele Lau

    Sell10b5-1 planMcKesson

    $2.7M

    Filed 05/27

Truth Social post of June 25, 2026 | Whalegun